Journal of Musculoskeletal Trauma

Original Article

Scaphocapitate Fusion for Kienbock disease: Jun Young Yang, Hyun Dae Shin, Sang Ro Ahn, Kwang Jin Rhee, Jun Kue Lee, Jung Hee Choi; J Korean Soc Fract 1999;12(2):446-451. Published online April 30, 1999; DOI: https://doi.org/10.12671/jksf.1999.12.2.446

We reviewed 14 patients treated with scaphocapitate fusion for Kienb.. ock's disease(Lichtman stage III) with mean follow-up of 26 months (ranging from 1 years to 5 year). There were five mens and nine womens. The mean age of patients at the time of operation was 46.1 years (ranging from thirty one to sixty). According to Lichtman's classification, All patients were stage III. Clinical assessments were evaluated using by pain relief, limitation in range of motion and clinical improvement. Radiologic assessment was evaluated by carpal height ratio. The mean range of motion is flexion 30 degree, extension 41 degree preoperatively, and flexion 29 degree, extension 41 degree postoperatively. The mean carpal height ratio is 0.49 preoperatively and 0.48 postoperatively. All of cases are relief of pain. Therefore radiographic and clinical satisfactory results were obtained. In conclusion, scaphocapitate fusion appear to be a very effective method for Lichtman stage III of symptomatic Kienb.. ock's disease.

Citations

Citations to this article as recorded by

Lunate Excision and Tendon Ball Implantation in Lichtman Stage IIIB Kienböck's Disease in Middle-Aged Patients
Sang Jin Cheon, Dong Ho Lee, Shi Hwan Park, Woong Ki Jeon
Journal of the Korean Society for Surgery of the Hand.2015; 20(3): 110. CrossRef

59 View
0 Download
1 Crossref

First
Prev
Page of 1
Next
Last

Search